Illumina, Inc. vs Standard Lithium Ltd — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Illumina, Inc. is far larger — about 48.2× Standard Lithium Ltd's market cap, and Illumina, Inc. is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| ILMN | SLI | |
|---|---|---|
Market Cap | $29.12B | $604.50M |
Sector | Health | Basic Materials |
52-Week High | $205.10 | $5.65 |
52-Week Low | $91.00 | $1.93 |
Enterprise Value | $30.48B | $467.42M |
Trailing returns across standard periods
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →